Skip to main content

MoneyWorks4Me

Shilpa Medicare informs about disclosure

19 Jan 2024 Evaluate
Shilpa Medicare has informed that Shilpa Medicare, headquartered at Raichur, Karnataka, India, has received Marketing Authorization from Germany, EU for Amifampridine Tablets, 10 mg under the National Procedure.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..